T. Suarez

1.2k total citations · 1 hit paper
8 papers, 947 citations indexed

About

T. Suarez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, T. Suarez has authored 8 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in T. Suarez's work include Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). T. Suarez is often cited by papers focused on Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). T. Suarez collaborates with scholars based in United States, Mexico and Russia. T. Suarez's co-authors include Mikhail Lichinitser, Javier Gutiérrez Santamarı́a, Jie Wang, Yoon‐Koo Kang, Won Ki Kang, Jianping Xiong, Jingyu Chen, Р. Ш. Хасанов, P. McCloud and Gerhard Förster and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Annals of Oncology.

In The Last Decade

T. Suarez

7 papers receiving 916 citations

Hit Papers

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as... 2009 2026 2014 2020 2009 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
    2009 582 citations Yoon‐Koo Kang, Won Ki Kang et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Suarez United States 6 595 515 413 254 139 8 947
Mi Ran Jung South Korea 17 649 1.1× 454 0.9× 301 0.7× 320 1.3× 72 0.5× 58 934
Soichi Fumita Japan 10 230 0.4× 132 0.3× 277 0.7× 130 0.5× 16 0.1× 22 468
Susanne Blank Germany 20 881 1.5× 722 1.4× 204 0.5× 304 1.2× 35 0.3× 53 1.1k
Jin Matsuyama Japan 15 715 1.2× 491 1.0× 328 0.8× 263 1.0× 153 1.1× 95 1.0k
Kiyoshi Ishigure Japan 15 467 0.8× 397 0.8× 364 0.9× 122 0.5× 127 0.9× 91 808
José Dinis Portugal 11 127 0.2× 226 0.4× 219 0.5× 23 0.1× 83 0.6× 29 493
Kazuhito Tsuchida Japan 14 531 0.9× 421 0.8× 198 0.5× 134 0.5× 190 1.4× 57 751
Hiroaki Mieno Japan 18 508 0.9× 359 0.7× 138 0.3× 219 0.9× 16 0.1× 53 716
Luis Gramática Argentina 12 134 0.2× 781 1.5× 119 0.3× 22 0.1× 41 0.3× 40 925
Joo-Ho Lee South Korea 11 1.1k 1.9× 532 1.0× 249 0.6× 709 2.8× 44 0.3× 14 1.3k

Countries citing papers authored by T. Suarez

Since Specialization
Citations

This map shows the geographic impact of T. Suarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Suarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Suarez more than expected).

Fields of papers citing papers by T. Suarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Suarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Suarez. The network helps show where T. Suarez may publish in the future.

Co-authorship network of co-authors of T. Suarez

This figure shows the co-authorship network connecting the top 25 collaborators of T. Suarez. A scholar is included among the top collaborators of T. Suarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Suarez. T. Suarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kang, Yoon‐Koo, Won Ki Kang, D.B. Shin, et al.. (2009). Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial. Annals of Oncology. 20(4). 666–673. 582 indexed citations breakdown →
2.
3.
4.
5.
Kang, Yoon‐Koo, Won Ki Kang, Donghyun Shin, et al.. (2006). Randomized phase III trial of capecitabine/cisplatin (XP) vs. continuous infusion of 5-FU/cisplatin (FP) as first-line therapy in patients (pts) with advanced gastric cancer (AGC): Efficacy and safety results. Journal of Clinical Oncology. 24(18_suppl). LBA4018–LBA4018. 72 indexed citations
6.
Aapro, Matti, Steven M. Grunberg, George Manikhas, et al.. (2006). A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Annals of Oncology. 17(9). 1441–1449. 265 indexed citations
7.
Suarez, T., Karim Fizazi, Yasmin Rahim, et al.. (2006). A randomized trial of denosumab (AMG 162) versus intravenous (IV) bisphosphonates (BP) in cancer patients (pts) with bone metastases (BM) on established IV BP and evidence of elevated bone resorption. Journal of Clinical Oncology. 24(18_suppl). 8562–8562. 11 indexed citations
8.
Suarez, T., et al.. (1997). [Bladder lithiasis formed from an IUD. A rare case].. PubMed. 50(7). 808–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mi Ran Jung Breakdown of academic impact, for papers by Soichi Fumita Breakdown of academic impact, for papers by Susanne Blank Breakdown of academic impact, for papers by Jin Matsuyama Breakdown of academic impact, for papers by Kiyoshi Ishigure Breakdown of academic impact, for papers by José Dinis Breakdown of academic impact, for papers by Kazuhito Tsuchida Breakdown of academic impact, for papers by Hiroaki Mieno Breakdown of academic impact, for papers by Luis Gramática Breakdown of academic impact, for papers by Joo-Ho Lee
Rankless by CCL
2026